Amarantus Bioscience Holdings, Inc.
(Other OTC/NBB : AMBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.95%176.301.2%$600.82m
GILDGilead Sciences, Inc.
0.62%68.020.9%$542.46m
BIIBBiogen Inc.
-0.06%280.401.2%$519.30m
CELGCelgene Corporation
-2.01%78.371.2%$513.71m
REGNRegeneron Pharmaceuticals, Inc.
-2.01%301.812.6%$316.79m
ALXNAlexion Pharmaceuticals, Inc.
-0.07%121.072.0%$253.26m
ILMNIllumina, Inc.
0.45%269.673.5%$244.32m
VRTXVertex Pharmaceuticals Incorporated
0.58%157.241.9%$236.54m
NKTRNektar Therapeutics
7.66%85.306.0%$212.18m
AAgilent Technologies, Inc.
1.15%64.321.5%$199.05m
INCYIncyte Corporation
1.79%67.832.5%$194.51m
SRPTSarepta Therapeutics, Inc.
1.78%93.4816.6%$131.29m
EXASExact Sciences Corporation
2.43%52.3625.5%$116.06m
BMRNBioMarin Pharmaceutical Inc.
0.51%88.884.4%$114.43m
ALNYAlnylam Pharmaceuticals, Inc
1.15%102.819.8%$103.66m

Company Profile

Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.